Hawkeye’s TEMPLAR Trial Approved in Denmark in Partnership with Vejle Hospital

Announcement
Written By Inform Solutions

Hawkeye’s TEMPLAR trial approved in Denmark for 3,000 patient prospective clinical trial in partnership’s with Vejle Hospital.

Inform Solutions

Inform Solutions serves as a trusted brand and communications partner to investment firms and their portfolio companies, establishing brand foundations and supporting go-to-market efforts that align with funding, growth, and acquisition goals. We further strengthen company positioning and thought leadership through clear, visually engaging long-form communications and reporting, helping organizations articulate their work with credibility and purpose.

https://inform.solutions/
Previous

ASCO Daily News: Lung Cancer Screening Remains Poor. Here’s How to Increase Rates and Save Lives
Next

Hawkeye expands TEMPLAR Clinical Trial Recruitment to Marmara University, Istanbul, Turkey